The Wall Street Journal

How a surfie who never finished uni became a biotech billionaire

How a surfie who never finished uni became a biotech billionaire
Bob Duggan is now said to be worth $25.6 billion. (Image: Summit Therapeutics)
The Wall Street Journal
By David WainerThere is a myth that making money in biotechnology stocks requires an advanced degree. But Bob Duggan, an avid surfie who never graduated from university, has proven that notion wrong. Twice.Duggan’s latest investment, Summit Therapeutics, has become one of the industry’s greatest bets in recent years. The stock is up more than 1,000% in the past 12 months thanks to data from a late-stage trial that showed that its drug, Ivonescimab, beat Merck’s blockbuster cancer drug Keytruda in patients with a form of l...

More Health

Green Cross Health navigates tough year with $16m profit
Markets

Green Cross Health navigates tough year with $16m profit

The company is navigating a 'challenging healthcare landscape'.

John Anthony 29 May 2025
Health NZ seeks ‘partnerships’ with major health contractors
Policy

Health NZ seeks ‘partnerships’ with major health contractors

The agency is establishing a major projects panel to tackle $6.4b pipeline.

Oliver Lewis 27 May 2025
Oceania dividend not expected for 'foreseeable future': Jarden
Property

Oceania dividend not expected for 'foreseeable future': Jarden

The retirement and aged care firm has signalled a change to its dividend policy.

Gregor Thompson 27 May 2025
Radius Care turns first profit in three years
News in Brief

Radius Care turns first profit in three years

Radius Care has reported its first net profit in three years and updated its dividend policy. The listed aged-care specialist reported net profit after tax (npat) of $7.4 million in its full-year financial results for the year to March 31, up from a loss of $8.5m previously.Under...

Gregor Thompson 21 May 2025